Clinical Diagnosis and Management of Alzheimer's Disease
Herausgeber: Gauthier, Serge
Clinical Diagnosis and Management of Alzheimer's Disease
Herausgeber: Gauthier, Serge
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The third edition of this successful textbook has been completely updated throughout and includes new chapters on electrophysiological tests, biological markers, global staging measures, and management of neuropsychiatric symptoms.
Andere Kunden interessierten sich auch für
- Behavioral Neurology in the Elderly82,99 €
- Fernando A. OliveiraCellular Mechanisms in Alzheimer's Disease132,99 €
- Brian DraperDealing with Dementia: A Guide to Alzheimer's Disease and Other Dementias20,99 €
- S. EliaAlzheimer's and Dementia: How to Reduce the Risks of Alzheimer's and Ways to Improve the Quality of Life: Why Some People Live a Long Healthy Li9,99 €
- Institute Of MedicineAlzheimer's Diagnostic Guideline Validation27,99 €
- Long-Term Management of Dementia87,99 €
- Kenneth I ShulmanQuick Cognitive Screening for Clinicians154,99 €
-
-
-
The third edition of this successful textbook has been completely updated throughout and includes new chapters on electrophysiological tests, biological markers, global staging measures, and management of neuropsychiatric symptoms.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- 3rd edition
- Seitenzahl: 408
- Erscheinungstermin: 5. September 2019
- Englisch
- Abmessung: 244mm x 188mm x 23mm
- Gewicht: 862g
- ISBN-13: 9780367389833
- ISBN-10: 0367389835
- Artikelnr.: 57732946
- Verlag: Taylor & Francis Ltd (Sales)
- 3rd edition
- Seitenzahl: 408
- Erscheinungstermin: 5. September 2019
- Englisch
- Abmessung: 244mm x 188mm x 23mm
- Gewicht: 862g
- ISBN-13: 9780367389833
- ISBN-10: 0367389835
- Artikelnr.: 57732946
Serge Gauthier
Section I: Introduction to the Disease Process 1. Definitions and
Diagnostic Criteria 2. Pathophysiology: A Neurochemical Perspective 3.
Pathophysiology: An Epidemiological Perspective Section II: Diagnosis 4.
Typical Clinical Features 5. Differentiation from Non-Alzheimer Dementias
6. Neuropsychological Assessment 7. Structural Brain Imaging 8. Functional
Brain Imaging 9. Electrophysiological Tests 10. Biological Markers Section
III: Natural Evolution 11. Natural Decline and Prognostic Factors 12.
Global Assessment Measures 13. Depressive Syndrome in Alzheimer's Disease
14. Cognition 15. Functional Automony 16. Behaviour Section IV: Medical
Management 17. Mild Cognitive Impairment and Very Early Stage Alzheimer's
Disease 18. Mild to Moderate Stages 19. Care of Patients in Severe Stage of
Dementia 20. Terminal Stage 21. Co-existent Medicial Problems and
Concomitant Diseases 22. Management of Neuropsychiatric Symptoms Section V:
Community and Institutional Management 23. Caregiver Support 24.
Community-based Formal Support Services Section VI: Ethical and Quality of
Life: Issues 25. Ethical Issues 26. Competency 27. Genetic Counselling 28.
Health-related Quality of Life Measurement Techniques in the Manage,ent of
Dementia Section VII: Conclusions 29. Future Diagnosis and Management of
Alzheimer's Disease
Diagnostic Criteria 2. Pathophysiology: A Neurochemical Perspective 3.
Pathophysiology: An Epidemiological Perspective Section II: Diagnosis 4.
Typical Clinical Features 5. Differentiation from Non-Alzheimer Dementias
6. Neuropsychological Assessment 7. Structural Brain Imaging 8. Functional
Brain Imaging 9. Electrophysiological Tests 10. Biological Markers Section
III: Natural Evolution 11. Natural Decline and Prognostic Factors 12.
Global Assessment Measures 13. Depressive Syndrome in Alzheimer's Disease
14. Cognition 15. Functional Automony 16. Behaviour Section IV: Medical
Management 17. Mild Cognitive Impairment and Very Early Stage Alzheimer's
Disease 18. Mild to Moderate Stages 19. Care of Patients in Severe Stage of
Dementia 20. Terminal Stage 21. Co-existent Medicial Problems and
Concomitant Diseases 22. Management of Neuropsychiatric Symptoms Section V:
Community and Institutional Management 23. Caregiver Support 24.
Community-based Formal Support Services Section VI: Ethical and Quality of
Life: Issues 25. Ethical Issues 26. Competency 27. Genetic Counselling 28.
Health-related Quality of Life Measurement Techniques in the Manage,ent of
Dementia Section VII: Conclusions 29. Future Diagnosis and Management of
Alzheimer's Disease
Section I: Introduction to the Disease Process 1. Definitions and
Diagnostic Criteria 2. Pathophysiology: A Neurochemical Perspective 3.
Pathophysiology: An Epidemiological Perspective Section II: Diagnosis 4.
Typical Clinical Features 5. Differentiation from Non-Alzheimer Dementias
6. Neuropsychological Assessment 7. Structural Brain Imaging 8. Functional
Brain Imaging 9. Electrophysiological Tests 10. Biological Markers Section
III: Natural Evolution 11. Natural Decline and Prognostic Factors 12.
Global Assessment Measures 13. Depressive Syndrome in Alzheimer's Disease
14. Cognition 15. Functional Automony 16. Behaviour Section IV: Medical
Management 17. Mild Cognitive Impairment and Very Early Stage Alzheimer's
Disease 18. Mild to Moderate Stages 19. Care of Patients in Severe Stage of
Dementia 20. Terminal Stage 21. Co-existent Medicial Problems and
Concomitant Diseases 22. Management of Neuropsychiatric Symptoms Section V:
Community and Institutional Management 23. Caregiver Support 24.
Community-based Formal Support Services Section VI: Ethical and Quality of
Life: Issues 25. Ethical Issues 26. Competency 27. Genetic Counselling 28.
Health-related Quality of Life Measurement Techniques in the Manage,ent of
Dementia Section VII: Conclusions 29. Future Diagnosis and Management of
Alzheimer's Disease
Diagnostic Criteria 2. Pathophysiology: A Neurochemical Perspective 3.
Pathophysiology: An Epidemiological Perspective Section II: Diagnosis 4.
Typical Clinical Features 5. Differentiation from Non-Alzheimer Dementias
6. Neuropsychological Assessment 7. Structural Brain Imaging 8. Functional
Brain Imaging 9. Electrophysiological Tests 10. Biological Markers Section
III: Natural Evolution 11. Natural Decline and Prognostic Factors 12.
Global Assessment Measures 13. Depressive Syndrome in Alzheimer's Disease
14. Cognition 15. Functional Automony 16. Behaviour Section IV: Medical
Management 17. Mild Cognitive Impairment and Very Early Stage Alzheimer's
Disease 18. Mild to Moderate Stages 19. Care of Patients in Severe Stage of
Dementia 20. Terminal Stage 21. Co-existent Medicial Problems and
Concomitant Diseases 22. Management of Neuropsychiatric Symptoms Section V:
Community and Institutional Management 23. Caregiver Support 24.
Community-based Formal Support Services Section VI: Ethical and Quality of
Life: Issues 25. Ethical Issues 26. Competency 27. Genetic Counselling 28.
Health-related Quality of Life Measurement Techniques in the Manage,ent of
Dementia Section VII: Conclusions 29. Future Diagnosis and Management of
Alzheimer's Disease